Skip to main content
Log in

Endoscopic evaluation of aceclofenac-induced gastroduodenal mucosal damage: a double-blind comparison with sodium diclofenac and placebo

  • Original Article
  • Published:
Japanese Journal of Rheumatology

Abstract

Gastroduodenal mucosal damage was endoscopically compared between aceclofenac, a non-steroidal anti-inflammatory drug, and sodium diclofenac or placebo in a double-blind clinical trial. Thirty healthy male volunteers received 150 mg/ day of aceclofenac, 75 mg/day of sodium diclofenac or placebo for 2 weeks. Aceclofenac caused significantly less gastropathy than sodium diclofenac, and placebo caused no gastropathy. Both the gastric mucosal hexosamine content and gastroduodenal blood flow were significantly reduced by sodium diclofenac, while gastric mucosal hexosamine was significantly increased and gastroduodenal blood flow was unchanged with aceclofenac. Aceclofenac appears to have a low potential for causing gastroduodenal mucosal damage in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fries JF, NSAID gastropathy: epidemiology,J Musculoskel Med 8, 21–28 (1991).

    Google Scholar 

  2. Ballesteros R, Ansoleaga JJ, Tapounet R, The efficacy and tolerance of aceclofenac in rheumatoid arthritis. A double-blind study vs. placebo,Clin Trials J 27, 12–19 (1990).

    Google Scholar 

  3. Giorgianni G, Ottaviani C, Soliano Aet al., Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis,Curr Ther. Res 51, 175–184 (1992).

    Google Scholar 

  4. Torri G, Vignati C, Agrifoglio E,et al., Aceclofenac versus piroxicam in the management of osteoarthritis of the knee,Curr Ther Res 55, 576–583 (1994).

    Article  Google Scholar 

  5. Birrell DH, Roma J, Bowdler JM, Evaluation of the efficacy and safety of aceclofenac in the treatment of osteoarthritis,Br J Clin Res 6, 45–55 (1995).

    Google Scholar 

  6. Mizushima Y, Phase II study of aceclofenac in patients with rheumatoid arthritis, Technical Report, Yakult Honsha Co., Ltd., Japan (1994).

    Google Scholar 

  7. Aoki T, Phase II study of aceclofenac in patients with osteoarthritis of the knee, Technical Report, Teikoku Hormone Manufacturing Co., Ltd., Japan (1994).

    Google Scholar 

  8. Lanza FL, Royer GL, Nelson RS,et al., The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers,Dig Dis Sci 24, 823–828 (1979).

    Article  CAS  PubMed  Google Scholar 

  9. Lanza FL, Royer GL, Nelson RS,et al., A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa,Am J Gastroenterol 75, 17–21 (1981).

    CAS  PubMed  Google Scholar 

  10. McCarthy DM, Nonsteroidal anti-inflammatory drug-induced ulcers. Management by traditional therapies,Gastroenterology 96, 662–674 (1989).

    CAS  PubMed  Google Scholar 

  11. Yanagawa A, Endo T, Nakagawa T,et al., Prophylactic efficacy of ranitidine against gastroduodenal mucosal damages from nonsteroidal anti-inflammatory drugs. A randomized placebocontrolled study,R Soc Med 21, 97–103 (1990).

    Google Scholar 

  12. Yanagawa A, Nakagawa T, Mizushima Y, Gastropathy due to nonsteroidal anti-inflammatory drugs and preventive effects of teprenone and H2-blockers,Jpn J Clin Exp Med 67, 941–946 (1990).

    Google Scholar 

  13. Yanagawa A, Fukumura T, Matsui H,et al., Possible mechanisms of gastroduodenal mucosal damage in volunteers treated with nonsteroidal antiinflammatory drugs. The usefulness of prodrug,J Rheumatol 19, 1075–1082 (1992).

    CAS  PubMed  Google Scholar 

  14. Saita H, Study of the measurement of gastric mucosal blood flow in rats using the laser doppler method,Gastroenterologia Japonica 81, 16–21 (1984).

    CAS  Google Scholar 

  15. Saita H, Reevaluation of gastric mucosal blood flow by the laser Doppler method,Gastroenterologia Japonica 86, 1235–1240 (1989).

    CAS  Google Scholar 

  16. Oketani K, Simple colorimetric assay method of mucoglycoprotein as an index of hexosamine,J Clin Exp Med 131, 745–749 (1984).

    CAS  Google Scholar 

  17. Azumi Y, Ohara S, Ishihara K, Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats,Gut 21 533–601 (1980).

    Article  Google Scholar 

  18. Neuhaus OW, Letzring M, Determination of hexosamines in conjugation with electrophoresis on starch,Anal Chem 29, 1230–1233 (1957).

    Article  CAS  Google Scholar 

  19. Grau M, Guasch J, Montero JL,et al., Pharmacology of the potent new non-steroidal antiinflammatory agent aceclofenac,Arzneim-Forsch 41, 1265–1276 (1991).

    CAS  Google Scholar 

  20. Pasero G, Ruju G, Marcolongo R,et al., Aceclofenac versus naproxen in the treatment of ankylosing spondylitis. A double-blind, controlled study,Curr Ther Res 55, 833–842 (1994).

    Article  Google Scholar 

  21. Agrifoglio E, Benventi M, Gatto P,et al., Aceclofenacn: A new NSAID in the treatment of acute lumbago. Multicentre single blind study vs. diclofenanc,Acta Therapeutica 20, 33–45 (1994).

    Google Scholar 

  22. Sainz Olall F, Analgesic efficacy of aceclofenac. Double-blind controlled study vs. placebo in odontalgia,Curr Ther Res 43, 900–902 (1988).

    Google Scholar 

  23. Movilia PG, Evaluation of the analgesic activity and tolerability of aceclofenac in the treatment of post-episiotomy pain,Drugs Exp Clin Res 15, 47–51 (1989).

    CAS  PubMed  Google Scholar 

  24. Puigvert Torrent A, Dose—response study of the analgesic activity of oceclogenac in odontalgia following extraction of the third molar,Drug Invest 2, 132–136 (1990).

    Google Scholar 

  25. Asaki S, Asaka M, Fujino M,et al., Endoscopic examination of gastric ulcers in rheumatoid arthritis patients during NSAIDs administration in Japan,Endoscopia Digestiva 5, 497–504 (1993).

    Google Scholar 

  26. Rimbau V, Fernandez MF, Guirao I,et al., Comparative study of the gastrointestinal tolerance of diclofenac and aceclofenac,ll Farmaco Ed Paractica 43, 19–26 (1988).

    CAS  Google Scholar 

  27. Wassif W, Bjarnason I, A comparison of the effects of aceclofenac and diclofenac on gastrointestinal blood loss,Br J Clin Res 3, 109–114 (1992).

    Google Scholar 

  28. Robert A, Prostaglandins and gastrointestinal tract, in:Physiology of the Gastrointestinal Tract, pp. 1407–1434, Raven Press, New York (1981).

    Google Scholar 

  29. Ligumisky M, Endogenous gastric prostaglandins, their role in mucosal integrity,Am J Physiol 242, G429-G432 (1982).

    Google Scholar 

  30. Takeuchi T, Mechanism of onset of indomethacin-induced gastropathy,Clin Rep 8, 167–177 (1989).

    Google Scholar 

  31. Peris F, Bird HA, Serni U,et al., Treatment compliance and safety of acecelofenac versus standard NSAIDs in patients with common arthritic disorders: a meta-analysis,Eur J Rheum Inflam 16, 37–45 (1996).

    Google Scholar 

  32. Yamazaki R, Matsuzaki T, Kaneda N,et al., Anti-inflammatory effect of aceclofenac on inflammation cells,Rheumatol in Eur 24 (suppl. 3), 273 (1995).

    Google Scholar 

  33. Dingle JT, The effect of NSAIDs on human articular cartilage glycosaminoglycan synthesis,Eur J Rheum Inflam 16, 47–52 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Yanagawa, A., Endo, T., Kusakari, K. et al. Endoscopic evaluation of aceclofenac-induced gastroduodenal mucosal damage: a double-blind comparison with sodium diclofenac and placebo. Japanese Journal of Rheumatology 8, 249–259 (1998). https://doi.org/10.1007/BF03041246

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03041246

Key words

Navigation